Publication:
Circulating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.

dc.contributor.authorMatejcic, M
dc.contributor.authorLesueur, F
dc.contributor.authorBiessy, C
dc.contributor.authorRenault, A L
dc.contributor.authorMebirouk, N
dc.contributor.authorYammine, S
dc.contributor.authorKeski-Rahkonen, P
dc.contributor.authorLi, K
dc.contributor.authorHémon, B
dc.contributor.authorWeiderpass, E
dc.contributor.authorRebours, V
dc.contributor.authorBoutron-Ruault, M C
dc.contributor.authorCarbonnel, F
dc.contributor.authorKaaks, R
dc.contributor.authorKatzke, V
dc.contributor.authorKuhn, T
dc.contributor.authorBoeing, H
dc.contributor.authorTrichopoulou, A
dc.contributor.authorPalli, D
dc.contributor.authorAgnoli, C
dc.contributor.authorPanico, S
dc.contributor.authorTumino, R
dc.contributor.authorSacerdote, C
dc.contributor.authorQuirós, J R
dc.contributor.authorDuell, E J
dc.contributor.authorPorta, M
dc.contributor.authorSanchez-Perez, Maria-Jose
dc.contributor.authorChirlaque, M D
dc.contributor.authorBarricarte, A
dc.contributor.authorAmiano, P
dc.contributor.authorYe, W
dc.contributor.authorPeeters, P H
dc.contributor.authorKhaw, K T
dc.contributor.authorPerez-Cornago, A
dc.contributor.authorKey, T J
dc.contributor.authorBueno-de-Mesquita, H B
dc.contributor.authorRiboli, E
dc.contributor.authorVineis, P
dc.contributor.authorRomieu, I
dc.contributor.authorGunter, M J
dc.contributor.authorChajès, V
dc.date.accessioned2023-01-25T10:21:26Z
dc.date.available2023-01-25T10:21:26Z
dc.date.issued2018-09-21
dc.description.abstractThere are both limited and conflicting data on the role of dietary fat and specific fatty acids in the development of pancreatic cancer. In this study, we investigated the association between plasma phospholipid fatty acids and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. The fatty acid composition was measured by gas chromatography in plasma samples collected at recruitment from375 incident pancreatic cancer cases and375 matched controls. Associations of specific fatty acids with pancreatic cancer risk were evaluated using multivariable conditional logistic regression models with adjustment for established pancreatic cancer risk factors. Statistically significant inverse associations were found between pancreatic cancer incidence and levels of heptadecanoic acid (ORT3-T1 [odds ratio for highest versus lowest tertile] =0.63; 95%CI[confidence interval] = 0.41-0.98; ptrend = 0.036), n-3 polyunsaturated α-linolenic acid (ORT3-T1 = 0.60; 95%CI = 0.39-0.92; ptrend = 0.02) and docosapentaenoic acid (ORT3-T1 = 0.52; 95%CI = 0.32-0.85; ptrend = 0.008). Industrial trans-fatty acids were positively associated with pancreatic cancer risk among men (ORT3-T1 = 3.00; 95%CI = 1.13-7.99; ptrend = 0.029), while conjugated linoleic acids were inversely related to pancreatic cancer among women only (ORT3-T1 = 0.37; 95%CI = 0.17-0.81; ptrend = 0.008). Among current smokers, the long-chain n-6/n-3 polyunsaturated fatty acids ratio was positively associated with pancreatic cancer risk (ORT3-T1 = 3.40; 95%CI = 1.39-8.34; ptrend = 0.007). Results were robust to a range of sensitivity analyses. Our findings suggest that higher circulating levels of saturated fatty acids with an odd number of carbon atoms and n-3 polyunsaturated fatty acids may be related to lower risk of pancreatic cancer. The influence of some fatty acids on the development of pancreatic cancer may be sex-specific and modulated by smoking.
dc.identifier.doi10.1002/ijc.31797
dc.identifier.essn1097-0215
dc.identifier.pmid30110135
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.31797
dc.identifier.urihttp://hdl.handle.net/10668/12836
dc.issue.number10
dc.journal.titleInternational journal of cancer
dc.journal.titleabbreviationInt J Cancer
dc.language.isoen
dc.organizationEscuela Andaluza de Salud Pública-EASP
dc.organizationHospital Universitario San Cecilio
dc.page.number2437-2448
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectbiomarkers
dc.subjectfatty acids
dc.subjectpancreatic cancer
dc.subjectplasma phospholipids
dc.subjecttobacco smoking
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCase-Control Studies
dc.subject.meshCohort Studies
dc.subject.meshEurope
dc.subject.meshFatty Acids
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPancreatic Neoplasms
dc.subject.meshPhospholipids
dc.subject.meshRisk
dc.titleCirculating plasma phospholipid fatty acids and risk of pancreatic cancer in a large European cohort.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number143
dspace.entity.typePublication

Files